Cover Image

Draft genome sequence of Catenibacterium mistuoki isolated from the fecal sample of a melanoma patient with complete response to immunotherapy

A strain of Catenibacterium spp. was isolated from a fecal sample of a patient diagnosed with stage IV melanoma in December 2008. The patient began treatment with the immune checkpoint inhibitor pembrolizumab in May 2016 and has since exhibited a sustained complete response to the therapy.

Saved in:
Main Author: Peñalba, Florencia (author)
Other Authors: Parada, Andrés (author), Elgul, Nabila (author), Alonso, María Isabel (author), Iraola, Gregorio (author), Berois, Nora (author), Osinaga, Eduardo (author), Riera Faraone, Nadia (author)
Format: article
Language:English
Published: 2025
Subjects:
Immunotherapy
Catenibactiruim
Anaerobes
Online Access:https://hdl.handle.net/20.500.12008/54082
Tags: Add Tag
No Tags, Be the first to tag this record!
Summary:A strain of Catenibacterium spp. was isolated from a fecal sample of a patient diagnosed with stage IV melanoma in December 2008. The patient began treatment with the immune checkpoint inhibitor pembrolizumab in May 2016 and has since exhibited a sustained complete response to the therapy.

Similar Items